Elevation of urinary adipsin in preeclampsia correlation with urine protein concentration and the potential use for a rapid diagnostic test

Hypertension

Volumn 64, Issue 4, 2014, Pages 846-851

  Wang, Tao ^a   Zhou, Rong ^a   Gao, Linbo ^a   Wang, Yanyun ^a   Song, Changping ^a   Gong, Yunhui ^a   Jia, Jin ^a   Xiong, Wei ^a   Dai, Li ^a   Zhang, Lin ^a   Hu, Huaizhong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Preeclampsia; Protein creatinine ratio; Urinary adipsin; Urinary protein; Urinary rapid test

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; COMPLEMENT FACTOR D; CREATININE; FOLLISTATIN RELATED PROTEIN;

ADULT; BLOOD; BLOOD PRESSURE; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOASSAY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PROCEDURES; PROTEINURIA; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; URINE; YOUNG ADULT;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; COMPLEMENT FACTOR D; CREATININE; EARLY DIAGNOSIS; FEMALE; FOLLISTATIN-RELATED PROTEINS; HUMANS; IMMUNOASSAY; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84914122148     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02688     Document Type: Article

References (25)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365: 785-799.
2. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97: 533-538.
3. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111: 649-658.
4. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350: 672-683.
5. Buhimschi CS, Baumbusch MA, Dulay AT, Lee S, Wehrum M, Zhao G, Bahtiyar MO, Pettker CM, Ali UA, Funai EF, Buhimschi IA. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: Comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio. BJOG. 2010;117: 321-330.
6. Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y, Suzuki M. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia. Hypertension. 2011;58: 859-866.
7. Gudnasson HM, Dubiel M, Gudmundsson S. Preeclampsia-abnormal uterine artery Doppler is related to recurrence of symptoms during the next pregnancy. J Perinat Med. 2004;32: 400-403.
8. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007;2: 543-549.
9. Cornelis T, Odutayo A, Keunen J, Hladunewich M. The kidney in normal pregnancy and preeclampsia. Semin Nephrol. 2011;31: 4-14.
10. Lafayette R. The kidney in preeclampsia. Kidney Int. 2005;67: 1194-1203.
11. Comper WD, Osicka TM. Detection of urinary albumin. Adv Chronic Kidney Dis. 2005;12: 170-176.
12. Ralston SH, Caine N, Richards I, O'Reilly D, Sturrock RD, Capell HA. Screening for proteinuria in a rheumatology clinic: Comparison of dipstick testing, 24 hour urine quantitative protein, and protein/creatinine ratio in random urine samples. Ann Rheum Dis. 1988;47: 759-763.
13. Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): How to screen for and detect onset of pre-eclampsia in the community. BMJ. 2005;330: 576-580.
14. Wang T, Zhou R, Zhang L, Wang Y, Song Cp, Lin W, Niu X, Lin Y, Hu H. Proteins in leaked amniotic fluid as biomarkers diagnostic for prelabor rupture of membranes. Proteomics Clin Appl. 2011;5: 415-421.
15. Dahlke K, Wrann CD, Sommerfeld O, Sossdorf M, Recknagel P, Sachse S, Winter SW, Klos A, Stahl GL, Ma YX, Claus RA, Reinhart K, Bauer M, Riedemann NC. Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis. J Immunol. 2011;186: 3066-3075.
16. Yamauchi Y, Stevens JW, Macon KJ, Volanakis JE. Recombinant and native zymogen forms of human complement factor D. J Immunol. 1994;152: 3645-3653.
17. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11: 85-97.
18. Inagi R, Miyata T, Oda O, Maeda K, Inoue K. Evaluation of the proteolytic activity of factor D accumulated as an active serine protease in patients with chronic renal failure. Nephron. 1994;66: 285-290.
19. Miyata T, Oda O, Inagi R, Sugiyama S, Miyama A, Maeda K, Nakashima I, Yamanaka N. Molecular and functional identification and purification of complement component factor D from urine of patients with chronic renal failure. Mol Immunol. 1990;27: 637-644.
20. Volanakis JE, Barnum SR, Giddens M, Galla JH. Renal filtration and catabolism of complement protein D. N Engl J Med. 1985;312: 395-399.
21. Pascual M, Steiger G, Estreicher J, Macon K, Volanakis JE, Schifferli JA. Metabolism of complement factor D in renal failure. Kidney Int. 1988;34: 529-536.
22. Gangaram R, Naicker M, Moodley J. Accuracy of the spot urinary microalbumin: Creatinine ratio and visual dipsticks in hypertensive pregnant women. Eur J Obstet Gynecol Reprod Biol. 2009;144: 146-148.
23. Abebe J, Eigbefoh J, Isabu P, Okogbenin S, Eifediyi R, Okusanya B. Accuracy of urine dipsticks, 2-h and 12-h urine collections for protein measurement as compared with the 24-h collection. J Obstet Gynaecol. 2008;28: 496-500.
24. Gangaram R, Ojwang PJ, Moodley J, Maharaj D. The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. Hypertens Pregnancy. 2005;24: 117-123.
25. Phelan LK, Brown MA, Davis GK, Mangos G. A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia. Hypertens Pregnancy. 2004;23: 135-142.